Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | GGT1 | P19440 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL766735 | 1.00 | SMN1; SMN2 (0.35) | SMN1; SMN2HIF1ATHRBKDM4EMAPT | |
| SCHEMBL14784873 | 0.81 | SMN1; SMN2 (0.33) | SMN1; SMN2HIF1ATHRBKDM4EMAPT | |
| SCHEMBL31296136 | 0.77 | SMN1; SMN2 (0.37) | SMN1; SMN2HIF1ATHRBGGT1MEN1 | |
| SCHEMBL7253604 | 0.77 | ALDH1A1 (0.41) | SMN1; SMN2HIF1ATHRBGGT1MEN1 | |
| SCHEMBL1005537 | 0.77 | SMN1; SMN2 (0.37) | SMN1; SMN2HIF1ATHRBKDM4EGGT1 | |
| SCHEMBL11872169 | 0.75 | HIF1A (0.44) | SMN1; SMN2HIF1ATHRBKDM4EGGT1 | |
| SCHEMBL22612007 | 0.75 | HIF1A (0.44) | SMN1; SMN2HIF1ATHRBKDM4EGGT1 | |
| SCHEMBL121974 | 0.73 | SMN1; SMN2 (0.34) | SMN1; SMN2HIF1ATHRBGGT1MEN1 | |
| SCHEMBL3921490 | 0.73 | SMN1; SMN2 (0.34) | SMN1; SMN2HIF1ATHRBGGT1MEN1 | |
| SCHEMBL20636765 | 0.73 | ODC1 (0.38) | SMN1; SMN2HIF1ATHRBKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024081619-A1 | CHELATING COMPOSITIONS AND METHODS OF USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-04-18 | — | — | WO | claimed |
| WO-2023220567-A1 | HEPATOPROTECTIVE COMPOSITIONS AND METHODS | Compound Solutions, Inc. (US) | 2023-11-16 | — | — | WO | claimed |
| WO-2022081716-A1 | METHODS OF TREATING IGA NEPHROPATHY WITH THIOL-CONTAINING MOLECULES | Accubit LLC - Biotechnology (US) | 2022-04-21 | — | — | WO | claimed |
| WO-2024206366-A2 | GENETICALLY ENCODED SYSTEM FOR QUANTIFYING RUBISCO ACTIVITY IN CATALYZING CARBON FIXATION | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024151520-A1 | FILTRATION AID COMPOSITIONS AND METHODS OF USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-4384193-A2 | GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY TO REDUCE INSTANT BLOOD MEDIATED INFLAMMATORY REACTIONS | Sana Biotechnology, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| US-20240139107-A1 | DENDRIMER-N-ACETYL-L-CYSTEINE CONJUGATES FOR TREATMENT OR PREVENTION OF AGING SKIN OR OTHER INDICATIONS | TRANSDERMAL BIOTECHNOLOGY, INC. (US) | 2024-05-02 | — | — | US | disclosed |
| WO-2024081619-A1 | CHELATING COMPOSITIONS AND METHODS OF USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-04-18 | — | — | WO | disclosed |
| WO-2024030816-A1 | COMPOSITIONS AND METHODS FOR CLEANING HIGH VISCOSITY SUBSTANCES FROM STORAGE AND TRANSPORT VESSELS | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-02-08 | — | — | WO | disclosed |
| WO-2024011212-A1 | MATERIALS AND METHODS FOR CONTROL OF IRON-CAPTURING PATHOGENS | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-01-11 | — | — | WO | disclosed |
| WO-2024011215-A1 | MATERIALS AND METHODS FOR REMEDIATING AND MITIGATING IRON POLLUTION | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-01-11 | — | — | WO | disclosed |
| US-20100102218-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG | CITY OF HOPE | 2010-04-29 | — | — | US | disclosed |
| EP-1272843-B1 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | NIADYNE CORP (US) | 2007-06-20 | — | — | EP | disclosed |
| US-20070105092-A1 | Proteolytic and covalent antibodies | COVALENT BIOSCIENCE INCORPORATED | 2007-05-10 | — | — | US | disclosed |
| EP-1615946-A2 | PROTEOLYTIC AND COVALENT ANTIBODIES | The University of Texas (US) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004087735-A2 | PROTEOLYTIC AND COVALENT ANTIBODIES | THE UNIVERSITY OF TEXAS (US) | 2004-10-14 | — | — | WO | disclosed |
| US-6716635-B2 | MIXING A SUBSTANCE TO BE TESTED, A HISTONE H1 AND ADP-RIBOSE AND MEASURING THE FLUORESCENCE AND PROTEIN CROSSLINKING; COMBINATORIAL LIBRARIES; ANTIDIABETIC AGENTS; ATHEROSCLEROSIS, CHRONIC NEURODEGENERATIVE DISEASES, E.G.,ALZHEIMER'S; | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2004-04-06 | — | — | US | disclosed |
| EP-1272843-A2 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | Niadyne Corporation (US) | 2003-01-08 | — | — | EP | disclosed |
| US-20020037496-A1 | Method for identifying regulators of protein-advanced glycation end product (protein-AGE) formation | NIADYNE, INC. | 2002-03-28 | — | — | US | disclosed |
| WO-2001079842-A2 | METHOD FOR IDENTIFYING REGULATORS OF PROTEIN-AGE FORMATION | NIADYNE CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |